The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Open accessAbstract
Background Eosinophilic airway inflammation is heterogeneous in asthmatic patients. We recently described a distinct subtype of asthma defined by the expression of genes inducible by TH2 cytokines in bronchial epithelium. This gene signature, which includes periostin, is present in approximately half of asthmatic patients and correlates with eosinophilic airway inflammation. However, identification of this subtype depends on invasive airway sampling, and hence noninvasive biomarkers of this phenotype are desirable. Objective We sought to identify systemic biomarkers of eosinophilic airway inflammation in asthmatic patients. Methods We measured fraction of exhaled nitric oxide (Feno), peripheral blood eosinophil, periostin, YKL-40, and IgE levels and compared these biomarkers with airway eosinophilia in asthmatic patients. Results We collected sputum, performed bronchoscopy, and matched peripheral blood samples from 67 asthmatic patients who remained symptomatic despite maximal inhaled corticosteroid treatment (mean FEV1, 60% of predicted value; mean Asthma Control Questionnaire [ACQ] score, 2.7). Serum periostin levels are significantly increased in asthmatic patients with evidence of eosinophilic airway inflammation relative to those with minimal eosinophilic airway inflammation. A logistic regression model, including sex, age, body mass index, IgE levels, blood eosinophil numbers, Feno levels, and serum periostin levels, in 59 patients with severe asthma showed that, of these indices, the serum periostin level was the single best predictor of airway eosinophilia (P = .007). Conclusion Periostin is a systemic biomarker of airway eosinophilia in asthmatic patients and has potential utility in patient selection for emerging asthma therapeutics targeting TH2 inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. O., Olin, A.-C., Plummer, A. L., & Taylor, D. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.9120-11st · Cited by 2,539
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Self-citationThe development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Self-citationAsthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Self-citationLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Self-citationMepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
Anderson, G. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61452-x · Cited by 999
Juniper, E. F., Bousquet, J., Abetz, L., & Bateman, E. D. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2005.08.012 · Cited by 998
The cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
SIMPSON, J. L., SCOTT, R., BOYLE, M. J., & GIBSON, P. G. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00784.x · Cited by 955
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828
Self-citationWENZEL, S. E., SZEFLER, S. J., LEUNG, D. Y. M., SLOAN, S. I., REX, M. D., & MARTIN, R. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9610046 · Cited by 754
A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma
Flood-Page, P., Swenson, C., Faiferman, I., Matthews, J., Williams, M., Brannick, L., Robinson, D., Wenzel, S., Busse, W., Hansel, T. T., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-085oc · Cited by 750
Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study
Castro, M., Mathur, S., Hargreave, F., Boulet, L.-P., Xie, F., Young, J., Wilkins, H. J., Henkel, T., & Nair, P. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0396oc · Cited by 716
Treatment strategies for allergy and asthma
Holgate, S. T., & Polosa, R. (2008) · Nature Reviews Immunology · doi:10.1038/nri2262 · Cited by 691
Takayama, G., Arima, K., Kanaji, T., Toda, S., Tanaka, H., Shoji, S., McKenzie, A. N. J., Nagai, H., Hotokebuchi, T., & Izuhara, K. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.046 · Cited by 674
IL-13 receptors and signaling pathways: An evolving web
Hershey, G. K. K. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1333 · Cited by 610
Distinguishing severe asthma phenotypes
Miranda, C., Busacker, A., Balzar, S., Trudeau, J., & Wenzel, S. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.041 · Cited by 586
A Chitinase-like Protein in the Lung and Circulation of Patients with Severe Asthma
Chupp, G. L., Lee, C. G., Jarjour, N., Shim, Y. M., Holm, C. T., He, S., Dziura, J. D., Reed, J., Coyle, A. J., Kiener, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073600 · Cited by 547
Blanchard, C., Mingler, M. K., Vicario, M., Abonia, J. P., Wu, Y. Y., Lu, T. X., Collins, M. H., Putnam, P. E., Wells, S. I., & Rothenberg, M. E. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.024 · Cited by 455
Eosinophilic and Neutrophilic Inflammation in Asthma: Insights from Clinical Studies
Fahy, J. V. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200808-087rm · Cited by 389
Self-citationSidhu, S. S., Yuan, S., Innes, A. L., Kerr, S., Woodruff, P. G., Hou, L., Muller, S. J., & Fahy, J. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009426107 · Cited by 384
Self-citationDaily versus As-Needed Corticosteroids for Mild Persistent Asthma
Boushey, H. A., Sorkness, C. A., King, T. S., Sullivan, S. D., Fahy, J. V., Lazarus, S. C., Chinchilli, V. M., Craig, T. J., Dimango, E. A., Deykin, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042552 · Cited by 383
Self-citationLeung, D. Y., Martin, R. J., Szefler, S. J., Sher, E. R., Ying, S., Kay, A. B., & Hamid, Q. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.33 · Cited by 348
Self-citationThe Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial
Shaw, D. E., Berry, M. A., Thomas, M., Green, R. H., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1427oc · Cited by 341
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
Shikotra, A., Choy, D. F., Ohri, C. M., Doran, E., Butler, C., Hargadon, B., Shelley, M., Abbas, A. R., Austin, C. D., Jackman, J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.031 · Cited by 333
Self-citationHumbert, M., Durham, S. R., Kimmitt, P., Powell, N., Assoufi, B., Pfister, R., Menz, G., Kay, A. B., & Corrigan, C. J. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70028-9 · Cited by 314
Effects of steroid therapy on inflammatory cell subtypes in asthma
Cowan, D. C., Cowan, J. O., Palmay, R., Williamson, A., & Taylor, D. R. (2010) · Thorax · doi:10.1136/thx.2009.126722 · Cited by 310
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses
Blanchard, C., Mingler, M. K., McBride, M., Putnam, P. E., Collins, M. H., Chang, G., Stringer, K., Abonia, J. P., Molkentin, J. D., & Rothenberg, M. E. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.15 · Cited by 280
Severe asthma in adults: What are the important questions?
Chanez, P., Wenzel, S. E., Anderson, G. P., Anto, J. M., Bel, E. H., Boulet, L.-P., Brightling, C. E., Busse, W. W., Castro, M., Dahlen, B., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.702 · Cited by 277
Baril, P., Gangeswaran, R., Mahon, P. C., Caulee, K., Kocher, H. M., Harada, T., Zhu, M., Kalthoff, H., Crnogorac-Jurcevic, T., & Lemoine, N. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210009 · Cited by 275
Dweik, R. A., Sorkness, R. L., Wenzel, S., Hammel, J., Curran-Everett, D., Comhair, S. A. A., Bleecker, E., Busse, W., Calhoun, W. J., Castro, M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0695oc · Cited by 270
Noneosinophilic asthma: A distinct clinical and pathologic phenotype
Haldar, P., & Pavord, I. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.02.042 · Cited by 263
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
Oh, C. K., Geba, G. P., & Molfino, N. (2010) · European Respiratory Review · doi:10.1183/09059180.00007609 · Cited by 256
Increased sputum and bronchial biopsy IL-13 expression in severe asthma
Saha, S. K., Berry, M. A., Parker, D., Siddiqui, S., Morgan, A., May, R., Monk, P., Bradding, P., Wardlaw, A. J., Pavord, I. D., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.005 · Cited by 255
Self-citationComparison of airway immunopathology of eosinophilic bronchitis and asthma
Brightling, C. E. (2003) · Thorax · doi:10.1136/thorax.58.6.528 · Cited by 239
Kudo, Y., Ogawa, I., Kitajima, S., Kitagawa, M., Kawai, H., Gaffney, P. M., Miyauchi, M., & Takata, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4540 · Cited by 214
Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.
Spieker-Polet, H., Sethupathi, P., Yam, P. C., & Knight, K. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9348 · Cited by 212
Lemière, C., Ernst, P., Olivenstein, R., Yamauchi, Y., Govindaraju, K., Ludwig, M. S., Martin, J. G., & Hamid, Q. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.003 · Cited by 204
Self-citationTruyen, E. (2006) · Thorax · doi:10.1136/thx.2005.052399 · Cited by 196
ANALYSIS OF NOVEL DISEASE-RELATED GENES IN BRONCHIAL ASTHMA
Yuyama, N., Davies, D. E., Akaiwa, M., Matsui, K., Hamasaki, Y., Suminami, Y., Yoshida, N. L., Maeda, M., Pandit, A., Lordan, J. L., et al. (2002) · Cytokine · doi:10.1006/cyto.2002.1972 · Cited by 194
Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer
Siriwardena, B. S. M. S., Kudo, Y., Ogawa, I., Kitagawa, M., Kitajima, S., Hatano, H., Tilakaratne, W. M., Miyauchi, M., & Takata, T. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603431 · Cited by 171
Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis
Berry, M. A., Parker, D., Neale, N., Woodman, L. B., Morgan, A. J., Monk, P., Bradding, P. H., Wardlaw, A. J., Pavord, I. D., & Brightling, C. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.032 · Cited by 155
Self-citationMulti‐dimensional phenotyping: towards a new taxonomy for airway disease
Wardlaw, A. J., Silverman, M. A., Siva, R., Pavord, I. D., & Green, R. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02344.x · Cited by 153
Elevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung Cancer
Sasaki, H., Yu, C., Dai, M., Tam‐Amersdorfer, C., Loda, M. F., Auclair, D., Chen, L. B., & ELIAS, A. D. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021899904332 · Cited by 143
Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma
Silkoff, P. E., LENT, A., Busacker, A. A., Katial, R. K., Balzar, S., Strand, M. J., & Wenzel, S. E. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.029 · Cited by 134
Hayashi, N., Yoshimoto, T., Izuhara, K., Matsui, K., Tanaka, T., & Nakanishi, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706378104 · Cited by 124
Stanković, K. M., Goldsztein, H., Reh, D. D., Platt, M. P., & Metson, R. B. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e31816b4b6f · Cited by 116
Sasaki, H., Auclair, D., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y., & Chen, L. B. (2001) · Cancer · Cited by 109
Plager, D. A., Kahl, J., Asmann, Y. W., Nilson, A. E., Pallanch, J. F., Friedman, O., & Kita, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011450 · Cited by 95
Expression of periostin in human breast cancer
Puglisi, F., Puppin, C., Pegolo, E., Andreetta, C., Pascoletti, G., D’Aurizio, F., Pandolfi, M., Fasola, G., Piga, A., Damante, G., et al. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.052506 · Cited by 91
Pavord, I. D., Jeffery, P. K., Qiu, Y., Zhu, J., Parker, D., Carlsheimer, Å., Naya, I. P., & Barnes, N. C. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.034 · Cited by 77
Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma
Macedo, P., Hew, M. J., Torregó, A., et al. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03319.x · Cited by 75
Sasaki, H., Lo, K.-M., Chen, L. B., Auclair, D., Nakashima, Y., Moriyama, S., Fukai, I., Tarn, C. Y., Loda, M. F., & Fujii, Y. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01174.x · Cited by 74
Changing pattern of sputum cell counts during successive exacerbations of airway disease
D’silva, L., Cook, R. J., Allen, C. J., Hargreave, F. E., & PARAMESWARAN, K. N. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.05.010 · Cited by 49
Walsh, G. M. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802591378 · Cited by 27
The Use of Exhaled Nitric Oxide in the Management of Asthma
Pavord, I. D., & Shaw, D. E. (2008) · Journal of Asthma · doi:10.1080/02770900801978557 · Cited by 26
Airways Disease: Phenotyping Heterogeneity Using Measures of Airway Inflammation
Siddiqui, S., & Brightling, C. E. (2007) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-3-2-60 · Cited by 14
Characterization of Novel Neutralizing Monoclonal Antibodies Specific to Human Neurturin
Hongo, J.-A. S., Tsai, S., Moffat, B., Schroeder, K. A., Jung, C., Chuntharapai, A., Lampe, P. A., Johnson, E. M., de Sauvage, F. J., Armanini, M. P., et al. (2000) · Hybridoma · doi:10.1089/027245700429855 · Cited by 9
Cited by
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
Self-citationType 2 inflammation in asthma — present in most, absent in many
Fahy, J. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3786 · Cited by 1,654
Self-citationUnderstanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Kuruvilla, M. E., Lee, F. E.-H., & Lee, G. B. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8712-1 · Cited by 1,228
Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.018 · Cited by 1,039
Self-citationExploring the Effects of Omalizumab in Allergic Asthma: An Analysis of Biomarkers in the EXTRA Study
Hanania, N. A., Wenzel, S., Rosén, K., Hsieh, H.-J., Mosesova, S., Choy, D. F., Lal, P., Arron, J. R., Harris, J. M., & Busse, W. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1414oc · Cited by 901
Self-citation
Metadata
- Authors
- Jia, G., Erickson, R. W., Choy, D. F., Mosesova, S., Wu, L. C., Solberg, O. D., Shikotra, A., Carter, R., Audusseau, S., Hamid, Q., Bradding, P., Fahy, J. V., Woodruff, P. G., Harris, J. M., & Arron, J. R.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 130
- Issue
- 3
- Pages
- 647-654.e10
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2063801679
- Cited by
- 615
- References
- 61
- FWCI
- 33.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.